Obergassel Justus, Heiduschka Peter, Alten Florian, Eter Nicole, Clemens Christoph R
Department of Ophthalmology, University of Muenster Medical Center, 48149 Muenster, Germany.
J Clin Med. 2024 Nov 19;13(22):6964. doi: 10.3390/jcm13226964.
The aim of this retrospective study was to compare the surgical and refractive outcomes using the Carlevale IOL (FIL SSF; SOLEKO) with those of the retropupillary-fixated Artisan IOL (Aphakia Model 205; OPHTEC), implanted through a 6 mm sclerocorneal tunnel incision in both groups. This study included 51 consecutive eyes (25 Carlevale and 26 Artisan IOLs). Due to complex preoperative conditions (e.g., dislocated polymethylmethacrylat IOL, luxated Cataracta rubra), all patients underwent lens explantation using a standardized 6 mm sclerocorneal tunnel incision and a 23 G or 25 G pars plana vitrectomy. Visual acuity (VA), spherical equivalent, refractive prediction error (PE), incision-suture time, and complication rates were recorded preoperatively and during the follow-up period. The average follow-up period was 40.9 ± 5.7 days. VA improved by 0.28 ± 0.39 logMAR ( < 0.0001) in the Carlevale group and by 0.36 ± 0.47 logMAR ( < 0.0001) in the Artisan group. The improvement was comparable between both groups ( = 0.921). The deviation of the PE was -0.67 ± 0.56 in the Carlevale group and 0.34 ± 0.71 in the Artisan group ( < 0.0001). The mean incision-suture time was 42.5 ± 5.8 min in the Carlevale group and 28.2 ± 6.4 min in the Artisan group. Anterior chamber and vitreous hemorrhages were the most common complications, occurring in 12% in the Carlevale group and 17.2% in the Artisan group. The use of the Carlevale IOL, implanted using a sclerocorneal tunnel technique, presents a valid option for treating complex lens dislocations. The scleral fixation of the Carlevale IOL minimizes risks associated with iris fixation, such as chronic inflammation and pupil distortion, making it particularly suitable for patients with damaged irises.
这项回顾性研究的目的是比较使用卡莱瓦尔人工晶状体（FIL SSF；SOLEKO）与经瞳孔固定的阿蒂桑人工晶状体（无晶状体模型205；OPHTEC）的手术和屈光结果，两组均通过6毫米巩膜隧道切口植入。本研究纳入了51只连续的眼睛（25只植入卡莱瓦尔人工晶状体，26只植入阿蒂桑人工晶状体）。由于术前情况复杂（如聚甲基丙烯酸甲酯人工晶状体脱位、红色白内障脱位），所有患者均采用标准化的6毫米巩膜隧道切口和23G或25G玻璃体切除术进行晶状体摘除。记录术前及随访期间的视力（VA）、等效球镜度、屈光预测误差（PE）、切口缝合时间和并发症发生率。平均随访期为40.9±5.7天。卡莱瓦尔组的VA提高了0.28±0.39 logMAR（<0.0001），阿蒂桑组提高了0.36±0.47 logMAR（<0.0001）。两组之间的改善情况具有可比性（=0.921）。卡莱瓦尔组PE的偏差为-0.67±0.56，阿蒂桑组为0.34±0.71（<0.0001）。卡莱瓦尔组的平均切口缝合时间为42.5±5.8分钟，阿蒂桑组为28.2±6.4分钟。前房和玻璃体出血是最常见的并发症，卡莱瓦尔组发生率为12%，阿蒂桑组为17.2%。采用巩膜隧道技术植入的卡莱瓦尔人工晶状体为治疗复杂晶状体脱位提供了一种有效的选择。卡莱瓦尔人工晶状体的巩膜固定将与虹膜固定相关的风险降至最低，如慢性炎症和瞳孔变形，使其特别适合虹膜受损的患者。
